Parkwood »

Monte Rosa Therapeutics shares owned by Parkwood

Quarter-by-quarter ownership of Monte Rosa Therapeutics (GLUE) shares owned by Parkwood from 13F filings

Historical chart of Parkwood investment in Monte Rosa Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Monte Rosa Therapeutics held by Parkwood consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Monte Rosa Therapeutics by Parkwood

Quarter filed Position value Share count Share price at filing
2025-09-30 $5.2M 708k 7.41
2025-06-30 $3.2M 708k 4.51
2025-03-31 $3.3M 708k 4.64
2024-12-31 $2.2M 323k 6.94
2024-09-30 $2.3M 427k 5.30

More positions owned by Parkwood

Vanguard Total Stock Mkt Etf Etp (VTI)
Vanguard Ftse Emerging Marke Etp (VWO)
Ss Spdr S&p Biotech Etf Etp Call Option (XBI)
Axon Enterprise Common Stock (AXON)
Meta Platforms Inc-class A Common Stock (META)
Ishares 20 Year Treasury Bd Etp Call Option (TLT)
Advance Auto Parts Common Stock (AAP)
Amazon.com Common Stock (AMZN)
Td Synnex Corp Common Stock (SNX)
Alphabet Inc-cl C Common Stock (GOOG)
Canadian Natural Resources Common Stock (CNQ)
Ishares Bitcoin Trust Etf Etp (IBIT)
Cloudflare Inc - Class A Common Stock (NET)
Shopify Inc - Class A Common Stock (SHOP)
Elevance Health Common Stock (ELV)

View all positions for Parkwood

Top funds holding Monte Rosa Therapeutics

NEA Management Company
BVF
Versant Venture Management
Baker Bros. Advisors
BlackRock
Suvretta Capital Management
Vanguard Group
FMR
Aisling Capital Management
Alphabet
Geode Capital Management
Marshall Wace
State Street Corporation
Vestal Point Capital
Northern Trust

View all funds holding Monte Rosa Therapeutics